RFI - Isolator for aseptic inoculation of ATMP samples for sterility testing

Information

Denne bekendtgørelse er kun vejledende
eForm 4 Forhåndsmeddelelse eller vejledende periodisk bekendtgørelse, der kun er anvendt til informationsformål
21-05-2026 08:07 (GMT+02:00)

Indkøber

Oslo Universitetssykehus HF (hovedenhet) Oslo Universitetssykehus HF (hovedenhet)
Frank Sætre Frank Sætre
Postboks 4956 Nydalen
0424 OSLO
Norge
993467049

Kort beskrivelse

RFI
The Department of Cancer Treatment at Oslo University Hospital (OUS) is planning a procurement of an isolator intended for aseptic preparation and inoculation of Advanced Therapy Medicinal Product samples into culture bottles for sterility testing according to European Pharmacopoeia principles (Ph. Eur. 2.6.1 and/or Ph. Eur. 2.6.27). The isolator will be installed in a non-classified room and shall provide a controlled Grade A/ISO 5 aseptic working environment for the critical inoculation step. Please see attached document for requirements.

Please respond by 03.06.2026 at 12:00

The purpose of this request is to obtain an overview of available solutions in the market and gather technical information and price estimates. This request does not constitute a competition and implies no obligation to purchase. Information received will be used solely for procurement planning purposes.

Filer

Navn Størrelse
78100 RFI Isolator.pdf 307 KB

Mercell A/S

En del af Mercell, en af Europas ledende aktører inden for formidling af information mellem indkøber og leverandør på det professionelle marked. CVR nr. 25698851
Mercell A/S | B!NGS
Vesterbrogade 149
, 1620 København V, Danmark